Celebrating our 10th anniversary – Unlock our special offer today

Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Israel Procedure to acquire medical cannabis export licence updated ...
  • France Bill introduced to try legalising recreational cannabis based on German model ...
  • North Dakota - United States Over 15,000 signatures needed to get adult-use cannabis legalisation on ballot ...
  • Kentucky - United States Bill signed into law makes changes to medical cannabis regulation ...
  • Oklahoma - United States Bill on industrial hemp harvesting, selling, licences to governor for signature ...
  • Slovenia Cannabis public referendum approved with no date set ...
  • Kentucky - United States Medical cannabis amendment bill heads to governor ...
  • Brazil Senate approves making possession of cannabis a crime ...
  • Lithuania State budget allocates funds to testing THC levels in hemp ...
  • Slovenia Proposal approved for referendum on cannabis legalisation ...
  • Morocco Compulsory logo on cannabis products stipulated by ministry ...
  • United States HHS recommends rescheduling cannabis, now passes to DOJ ...
View all
News analysis

‘Snake oil’ claims for CBD and Covid-19 top latest list of US FDA warning letters

Written by || 29th December 2021 || News analysis | Health and science | GeographiesNorth America United States

The most common subject of recent warning letters from the US Food and Drug Administration (FDA) over unsubstantiated health claims was CBD products that were claimed to mitigate, prevent, treat, diagnose or cure Covid-19.

That’s revealed in a new study published by the Journal of Cannabis Research under the tag “Return of snake oil medicine”.

Read full article

Download the full news analysis

“‘Snake oil’ claims for CBD and Covid-19 top latest list of US FDA warning letters”








    I'm already a subscriber

    Login

    Author default picture

    Lorraine Mullaney

    Senior writer
    Lorraine is responsible for writing news analysis and assisting with copy-editing. Lorraine is a copywriter and editor who has written and edited words for a wide range of audiences, from local community newspapers to consumer magazines and trade websites.

    Our Key Benefits

    The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

    Thanks for getting in touch with us

    Please leave your enquiry and we will get back to you within 24 hours


      Sign up to our newsletter

      Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


        See more


        By signing up you agree to our Privacy Policy.